Abstract
We report a 69-year-old female with erythroblastopenia and thymoma who developed lesions of Kaposi's sarcoma (KS) after thymectomy, 2 months after the initiation of therapy with methylprednisolone. Control of mucocutaneous KS lesions was obtained with radiotherapy, interferon alfa-2b and withdrawal of systemic immunosuppressive therapy. Erosive oral lichen planus appeared later, and after therapy with topical corticosteroids a new lesion of KS developed that regressed after withdrawal of topical corticosteroids. The detection of HHV-8 only in lesional skin supports the hypothesis that this virus can trigger the development of KS lesions.
Author supplied keywords
Cite
CITATION STYLE
Pérez, E., Barnadas, M. A., García-Patos, V., Pedro, C., Curell, R., Sander, C. A., … Alomar, A. (1998). Kaposi’s sarcoma in a patient with erythroblastopenia and thymoma: Reactivation after topical corticosteroids. Dermatology, 197(3), 264–267. https://doi.org/10.1159/000018010
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.